Angiotensin I

Overview and Clinical Significance

Angiotensin I is a precursor hormone in the renin-angiotensin-aldosterone system (RAAS), which regulates blood pressure and fluid balance. It is formed when renin, an enzyme released by the kidneys, cleaves angiotensinogen (produced by the liver). Angiotensin I itself has no direct physiological activity, but it is rapidly converted into angiotensin II by angiotensin-converting enzyme (ACE), primarily in the lungs.

Clinical Significance

  • Hypertension & Cardiovascular Health: Angiotensin I is a key component in blood pressure regulation. Its conversion to angiotensin II leads to vasoconstriction, increasing blood pressure.
  • ACE Inhibitors & Blood Pressure Control: Medications like ACE inhibitors block the conversion of angiotensin I to angiotensin II, reducing hypertension and protecting against heart failure.
  • Shock & Critical Illness: In conditions like vasodilatory shock, altered angiotensin I levels may indicate catecholamine-resistant hypotension, affecting treatment strategies.
  • Kidney Function & Fluid Balance: Angiotensin I plays a role in sodium retention and renal perfusion, influencing kidney health and electrolyte balance.

Angiotensin I is primarily studied in cardiovascular and renal medicine, with its regulation being a target for hypertension treatment and fluid balance therapies.

‍

+

-

Regulation of Angiotensin I Production

  • Activated Renin–Angiotensin System (RAS):
    Increased renin activity—as might occur with dehydration, heart failure, or renal disorders—elevates angiotensin I.
  • Compensatory Mechanisms:
    In response to blood pressure drops or low sodium status, the production of angiotensin I may be boosted.

‍

RAS Suppression

  • Medication Effects & Suppressed Renin State:
    The use of ACE inhibitors, angiotensin receptor blockers (ARBs), or a suppressed renin state (as seen in some forms of hypertension) can lower angiotensin I production.

‍

More Info

Related

Age-Related Variations in RAS Peptides

  • In Newborns and Young Children:
    The renin–angiotensin system (RAS) is still developing, and baseline levels of its peptides may differ from those in adults.
  • In Older Adults:
    Changes in kidney function and hormonal regulation can affect the levels and activity of RAS peptides.

‍

Renin–Angiotensin–Aldosterone System (RAAS)

All these markers are components of the Renin–Angiotensin–Aldosterone System (RAAS), which regulates blood pressure, fluid balance, and electrolyte homeostasis:

  • Renin is produced by the kidneys and initiates the process by converting angiotensinogen into angiotensin I.
  • Angiotensin I serves as a precursor that is converted by Angiotensin Converting Enzyme (ACE) into the active Angiotensin II.
  • Angiotensin II is a potent vasoconstrictor that also stimulates the adrenal cortex to secrete Aldosterone.
  • Aldosterone, measured in both blood and urine, acts on the kidneys to enhance sodium and water retention, thereby increasing blood volume and pressure.

Together, these components work in a coordinated cascade to maintain cardiovascular stability and fluid balance.

‍

All Markers